Treatment of Acute Orofacial Pain with Lower Cervical Intramuscular Bupivacaine Injections: A 1-Year Retrospective Review of 114 Patients

Aims: To describe 1 year’s experience in treating orofacial pain with intramuscular injections of 0.5% bupivacaine bilateral to the spinous processes of the lower cervical vertebrae. Methods: A retrospective review of 2,517 emergency department patients with discharge diagnoses of a variety of orofacial pain conditions and 771 patients who were coded as having had an anesthetic injection between June 30, 2003 and July 1, 2004 was performed. The records of all adult patients who had undergone paraspinous intramuscular injection with bupivacaine for the treatment of an orofacial pain condition were extracted from these 2 databases and included in this retrospective review. Pain relief was reported in 2 different ways: (1) patients (n = 114) were placed in 1 of 4 orofacial pain relief categories based on common clinical experience and face validity and (2) pain relief was calculated based on patients’ (n = 71) ratings of their pain on a numerical descriptor scale before and after treatment. Results: Lower cervical paraspinous intramuscular injections with bupivacaine were performed in 118 adult patients. Four charts were excluded from review because of missing or inadequate documentation. Pain relief (complete or clinical) occurred in 75 patients (66%), and partial orofacial pain relief in 32 patients (28%). No significant relief was reported in 7 patients (6%). Overall, some therapeutic response was reported in 107 of 114 patients (94%). Orofacial pain relief was rapid, with many patients reporting complete relief within 5 to 15 minutes. Conclusion: This is the first report of a large case series of emergency department patients whose orofacial pain conditions were treated with intramuscular injections of bupivacaine in the paraspinous muscles of the lower neck. The findings suggest that lower cervical paraspinous intramuscular injections with bupivacaine may prove to be a new therapeutic option for acute orofacial pain in the emergency department setting.

allodynia; bupivacaine; cervical; headache; injection; intramuscular; orofacial; pain; paraspinous; trigeminocervical

1. Lipton JA, Ship J, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993;124:115–121.

2. Locker D, Grushka M. Prevalence of oral and facial pain and discomfort: Preliminary results of a mail survey. Community Dent Oral Epidemiol 1987;15:169–172.

3. McCaig LF, Nawar EN. National Hospital Ambulatory Medical Care Survey: 2004 Emergency Medical Department Summary. Advance Data from Vital and Health Statistics; no. 372. Hyattsville, MD: National Center for Health Statistics, 2006.

4. Mellick GA, Mellick LB. Regional head and face pain relief following lower cervical intramuscular anesthetic injection. Headache 2003;43:1109–1111.

5. Mellick LB, Mellick GA. Treatment of primary headache in the emergency department [letter]. Headache 2004;44:840–841.

6. Mellick LB, McIlrath ST, Mellick GA. Treatment of headaches in the ED with lower cervical intramuscular bupivacaine injections: A 1-year retrospective review of 417 patients. Headache 2006;46:1441–1449.

7. Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: Current concepts and synthesis. Curr Pain Headache Rep 2003;7:371–376.

8. Sessle BJ. Acute and chronic craniofacial pain: Brainstem mechanism of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 2000;11:57–91.

9. Mason P. Deconstructing endogenous pain modulation. J Neurophysiol 2005;94:1659–1663.

10. Cadden SW, Orchardson R. The neural mechanisms of oral and facial pain. Dent Update 2001;28:359–367.

11. Svensson P, Graven-Nielsen T. Craniofacial muscle pain: Review of mechanisms and clinical manifestations. J Orofac Pain 2001;15:117–145.

12. Newman LC, Lipton RB. Emergency department management of headache. Neurologic Clinics 1998;16:285–303.

13. Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep 2003;7:377–383.

14. Abrahams VC, Anstee G, Richmond FJ, Rose PK. Neck muscle and trigeminal input to the upper cervical cord and lower medulla of the cat. Can J Physiol Pharmacol 1979;57:642–651.

15. Piovesan EJ, Kowacs PA, Tatsui CE, Lange MC, Ribas LC, Werneck LC. Referred pain after painful stimulation of the greater occipital nerve in humans: Evidence of convergence of cervical afferences on trigeminal nuclei. Cephalalgia 2001;21:107–109.

16. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 2002;125:1496–1509.

17. Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain 2003;126: 1801–1813.

18. Ambrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: A double-blind placebo-controlled study. Pain 2005;118:92–96.

19. Hu JW, Sun KQ, Vernon H, Sessle BJ. Craniofacial inputs to upper cervical dorsal horn: Implications for somatosensory information processing. Brain Res 2005;1044: 93–106.

20. Browne PA, Clark GT, Kuboki T, Adachi MY. Concurrent cervical and craniofacial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:633–640.

21. Bogduk N. The neck and headaches. Neurol Clin 2004;22:151–171.

22. Armijo Olivo S, Magee DJ, Parfitt M, Major P, Thie NM. The association between the cervical spine, the stomatognathic system, and craniofacial pain: A critical review. J Orofac Pain 2006;20:271–287.

23. Carlson CR Okeson JP, Falace DA, Nitz A J, Lindroth JE. Reduction of pain and EMG activity in the masseter region by trapezius trigger point injection. Pain 1993;55: 397–400.

24. Busch V, Jakob W, Juergens T, Schulte-Mattler W, Kaube H, May A. Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes. Cephalalgia 2006;26:50–55.

25. Villanueva L, Le Bars D. The activation of bulbo-spinal controls by peripheral nociceptive inputs: Diffuse noxious inhibitory controls. Biol Res 1995;28:113–125.

26. Bouhassira D, Chitour D, Villaneuva L, Le Bars D. The spinal transmission of nociceptive information: Modulation by the caudal medulla. Neuroscience 1995;69: 931–938.

27. Raboisson P, Dallel R, Clavelou P, Sessle Bl, Woda A. Effects of subcutaneous formalin on the activity of trigeminal brain stem nociceptive neurons in the rat. J Neurophysiol 1995;73:496–505.

28. Bijur PE, Latimer CT, Gallagher J. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emer Med 2003;10: 390–392.

29. Holdgate A, Asha S, Craig J, Thompson J. Comparison of a verbal numeric rating scale with the visual analogue scale for the measurement of acute pain. Emerg Med (Fremantle) 2003;15:441–446.

30. Kendrick DB, Strout TD. The minimum clinically significant difference in patient-assigned numeric scores for pain. Am J Emerg Med 2005;23:828–832.

31. Cepeda MS, Africano JM, Polo R, Alcala R, Carr DB. What decline in pain intensity is meaningful to patients with acute pain? Pain 2003;105:151–157.